In the B78 model, RT increases OX40 expression on tumor CD4+ cells (Figure 5C) and increases T cell activation in the spleen and TDLN when combined with CpG+OX40 (Figures 6A, B). This evidence concerns the gene TNFRSF4 and neoplasm.